222 related articles for article (PubMed ID: 36749775)
1. Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2.
Cui S; Chen Y; Guo Y; Wang X; Chen D
PLoS One; 2023; 18(2):e0281536. PubMed ID: 36749775
[TBL] [Abstract][Full Text] [Related]
2. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
Zhang QY; Men CJ; Ding XW
J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
5. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-23b-3p promotes the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells by targeting Sprouty2.
Liu W; Yang Y; Yan J; Wang L
Acta Histochem; 2019 Aug; 121(6):704-711. PubMed ID: 31235073
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA‑27b contributes to the migration and invasion of gastric cancer cells via the inhibition of sprouty2‑mediated ERK signaling.
Jiang J; Yi B; Qin C; Ding S; Cao W
Mol Med Rep; 2016 Mar; 13(3):2267-72. PubMed ID: 26781754
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
Wang JR; Liu B; Zhou L; Huang YX
Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
[TBL] [Abstract][Full Text] [Related]
10. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.
Barbáchano A; Fernández-Barral A; Pereira F; Segura MF; Ordóñez-Morán P; Carrillo-de Santa Pau E; González-Sancho JM; Hanniford D; Martínez N; Costales-Carrera A; Real FX; Pálmer HG; Rojas JM; Hernando E; Muñoz A
Oncogene; 2016 Jun; 35(23):2991-3003. PubMed ID: 26455323
[TBL] [Abstract][Full Text] [Related]
11. miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Biochem Biophys Res Commun; 2022 Sep; 619():76-83. PubMed ID: 35749939
[TBL] [Abstract][Full Text] [Related]
12. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
13. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Sprouty homolog 2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells.
Wang JH; Zhou WW; Cheng ST; Liu BX; Liu FR; Song JQ
Mol Med Rep; 2015 Aug; 12(2):1810-6. PubMed ID: 25825239
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
16. miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K.
Gurbuz N; Kahraman N; Sonmez HE; Mokhlis HA; Kosar PA; Ozpolat B
Anticancer Agents Med Chem; 2022; 22(14):2607-2618. PubMed ID: 35718922
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factor FOXO3a Overexpression Inhibits the Progression of Neuroblastoma by Regulating the miR-21/SPRY2/ERK Axis.
Chen J; Xu Y; Wu P; Chen X; Weng W; Li D
World Neurosurg; 2022 Aug; 164():e99-e112. PubMed ID: 35405317
[TBL] [Abstract][Full Text] [Related]
18. MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition.
Ding X; Zhang J; Feng Z; Tang Q; Zhou X
Dig Dis Sci; 2021 Jul; 66(7):2272-2282. PubMed ID: 32749639
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
[Next] [New Search]